NCT00875251

Brief Summary

Growth is traditionally used as a prognostic measure after admission to a neonatal intensive care unit (NICU). Quality of neonatal intensive care is one of the factors determining the health and quality of life for those that survive, with the principal objective of increasing disability-free survival. Nowadays, there is some researches showing us that these preterm babies present a different body composition when they achieve term age compared with babies birth at term and this condition could be putting these babies in risk to metabolic syndrome early in adult age. The majority of infants born between 24 and 29 weeks of gestational age fail to achieve the mean birth weight for fetuses of the same gestational age, and many weigh below the 10th percentile at hospital discharge. The focus of this study is the growth and body composition of very low birth weight infants growing in the extrauterine environment. The central question is, when they reach the corresponding term weight, is the body composition of newborns growing outside of the uterus different from that of infants growing in the intrauterine environment? The investigators are also trying to validate 3 different methods to research body composition: DXA, air-displacement plethysmography and electric bioimpedance.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2009

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 2, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 3, 2009

Completed
12.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

September 18, 2020

Status Verified

September 1, 2020

Enrollment Period

12.8 years

First QC Date

April 2, 2009

Last Update Submit

September 17, 2020

Conditions

Keywords

body compositionpreterm infantanthropometry

Outcome Measures

Primary Outcomes (1)

  • body composition

    fat mass and fat free mass from PEA BOD

    from discharge to 3 months of chronological age

Secondary Outcomes (1)

  • anthropometry

    from term to first year of life

Study Arms (2)

term infants body composition

Term infants from 2 days of life to 7 days of life without IUGR

Device: body composition

preterm infants body composition

very low birth weight infants before discharge

Device: body composition

Interventions

Measurements of body composition using 2 differents devices: Bioimpedance measurements will be made with the RJL System (Quantum BIA 101Q equipment) air-displacement plethysmography in the PEA POD System (Life Measurement).

Also known as: air displacement plethysmography
preterm infants body compositionterm infants body composition

Eligibility Criteria

AgeUp to 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Preterm infants with birth weight less than 1500g Term infants without IUGR

You may qualify if:

  • appropriate for gestational age (AGA) and small for gestational age (SGA) premature newborns with gestational age less than or equal to 32 weeks and less than 1500g at birth
  • AGA term newborns with gestational age greater than or equal to 37 weeks and less than 42 weeks and with no history of maternal disease that might compromise intrauterine growth

You may not qualify if:

  • congenital malformations
  • genetic syndromes confirmed by the geneticist
  • clinically and laboratory-confirmed congenital infections
  • children of mothers with the human immunodeficiency virus (HIV)
  • children of diabetic mothers
  • newborns that develop severe intraventricular hemorrhage or necrotizing enterocolitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Instituto Fernandes Figueira

Rio de Janeiro, Rio de Janeiro, 22520-040, Brazil

ENROLLING BY INVITATION

Maria Elisabeth L Moreira

Rio de Janeiro, 22420040, Brazil

RECRUITING

Related Publications (1)

  • Nehab SR, Villela LD, Soares FVM, Abranches AD, Araujo DMR, da Silva LML, Amaral YNV, Junior SCG, Meio MDBB, Moreira ME. Gestational weight gain and body composition of full-term newborns and infants: a cohort study. BMC Pregnancy Childbirth. 2020 Aug 20;20(1):474. doi: 10.1186/s12884-020-03145-x.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Maria E Moreira, MD

    Oswaldo Cruz Foundation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maria E Moreira, MD; PhD

CONTACT

Dalva B Meio, MD; PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

April 2, 2009

First Posted

April 3, 2009

Study Start

April 1, 2009

Primary Completion

December 30, 2021

Study Completion

December 30, 2021

Last Updated

September 18, 2020

Record last verified: 2020-09

Locations